Name | Number of supported studies | Average coverage | |
---|---|---|---|
naive B cell | 4 studies | 17% ± 1% | |
epithelial cell | 4 studies | 26% ± 10% | |
dendritic cell | 3 studies | 27% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 3 studies | 22% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 1553.34 | 459 / 459 | 100% | 34.68 | 1118 / 1118 |
ovary | 100% | 1402.52 | 180 / 180 | 100% | 27.50 | 430 / 430 |
esophagus | 100% | 1311.89 | 1444 / 1445 | 100% | 30.34 | 183 / 183 |
intestine | 100% | 1282.37 | 966 / 966 | 100% | 31.52 | 526 / 527 |
lung | 100% | 1198.69 | 577 / 578 | 100% | 36.75 | 1154 / 1155 |
stomach | 100% | 947.20 | 359 / 359 | 100% | 27.99 | 285 / 286 |
bladder | 100% | 1474.76 | 21 / 21 | 100% | 31.90 | 502 / 504 |
uterus | 100% | 1577.04 | 170 / 170 | 100% | 39.48 | 457 / 459 |
prostate | 100% | 1158.88 | 245 / 245 | 99% | 22.65 | 499 / 502 |
pancreas | 100% | 754.06 | 328 / 328 | 99% | 21.71 | 176 / 178 |
thymus | 100% | 1221.36 | 653 / 653 | 99% | 20.63 | 597 / 605 |
brain | 99% | 715.22 | 2605 / 2642 | 100% | 26.16 | 705 / 705 |
skin | 100% | 1678.51 | 1809 / 1809 | 97% | 39.03 | 459 / 472 |
adrenal gland | 100% | 1059.21 | 258 / 258 | 93% | 18.56 | 213 / 230 |
liver | 100% | 551.48 | 225 / 226 | 93% | 15.09 | 376 / 406 |
kidney | 100% | 786.48 | 89 / 89 | 91% | 14.73 | 822 / 901 |
adipose | 100% | 1627.25 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 37.86 | 29 / 29 |
spleen | 100% | 1375.73 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 38.38 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.65 | 1 / 1 |
blood vessel | 100% | 1308.92 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1143.46 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 777.79 | 838 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 86% | 17.10 | 69 / 80 |
peripheral blood | 84% | 798.53 | 777 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_2000234 | Biological process | positive regulation of rRNA processing |
GO_0030490 | Biological process | maturation of SSU-rRNA |
GO_0042274 | Biological process | ribosomal small subunit biogenesis |
GO_0034708 | Cellular component | methyltransferase complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0030688 | Cellular component | preribosome, small subunit precursor |
GO_0016787 | Molecular function | hydrolase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | RIOK1 |
Protein name | Serine/threonine-protein kinase RIO1 (EC 2.7.11.1) (EC 3.6.3.-) (RIO kinase 1) RIO kinase 1 |
Synonyms | RIO1 |
Description | FUNCTION: Involved in the final steps of cytoplasmic maturation of the 40S ribosomal subunit. Involved in processing of 18S-E pre-rRNA to the mature 18S rRNA. Required for the recycling of NOB1 and PNO1 from the late 40S precursor . The association with the very late 40S subunit intermediate may involve a translation-like checkpoint point cycle preceeding the binding to the 60S ribosomal subunit (By similarity). Despite the protein kinase domain is proposed to act predominantly as an ATPase (By similarity). The catalytic activity regulates its dynamic association with the 40S subunit (By similarity). In addition to its role in ribosomal biogenesis acts as an adapter protein by recruiting NCL/nucleolin the to PRMT5 complex for its symmetrical methylation . . |
Accessions | ENST00000379834.7 ENST00000475351.5 Q9BRS2 E9PFQ8 |